Wendy A. Thomas

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.

R J Murray, Michael G. Kurilla, Jill Brooks et al. · The Journal of Experimental Medicine · 1992 · 506 citations · Full text

Life Sciences, Immunology, Oncology +17

Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy

S P Lee, Rosemary J. Tierney, Wendy A. Thomas et al. · The Journal of Immunology · 1997 · 208 citations

Life Sciences, Immunology, Oncology +17

The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for Degradation

Jianmin Zuo, Andrew Currin, Bryan D. Griffin et al. · PLoS Pathogens · 2009 · 207 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2

S P Lee, Wendy A. Thomas, R J Murray et al. · Journal of Virology · 1993 · 181 citations · Full text

Life Sciences, Immunology, Oncology +17

An Epstein-Barr Virus Anti-Apoptotic Protein Constitutively Expressed in Transformed Cells and Implicated in Burkitt Lymphomagenesis: The Wp/BHRF1 Link

Gemma L. Kelly, Heather M. Long, Julianna Stylianou et al. · PLoS Pathogens · 2009 · 172 citations · Full text

Life Sciences, Cell Biology, Oncology +17